logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fotios V. Michelis

hans messner allogeneic transplant program
H指数:23
被引数:2,107

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes

吸烟和异基因造血干细胞移植前合并症对肺移植物抗宿主病发生率和移植后结局的影响

Cancers
IF4.4
2026-01-180
OAAI
Ebaa Reda; Mohammed Kawari; Mariana Pinto Pereira; Mats Remberger; Ambrose Lau; Arjun D. Law; Rajat Kumar; Igor Novitzky-Basso; Wilson Lam; Ivan Pasic; Armin Gerbitz; Auro Viswabandya; Dennis D. Kim; Jeffrey H. Lipton; Jonas Mattsson; Fotios V. Michelis
Eltrombopag in Treating Post-Allogeneic Hematopoietic Stem Cell Transplantation Cytopenias: Efficacy, Response Durability, and Cost Benefit of Early Drug Tapering

Eltrombopag在治疗异基因造血干细胞移植后血细胞减少症中的应用：早期药物减量策略的有效性、应答持久性及成本效益分析

EUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
2025-12-011
PRE
Al-Omari, Rawan; Nampoothiri, Ram Vasudevan; Sakhdari, Ali; Atenafu, Eshetu G.; Chiarello, Caden; Kim, Dennis D.; Law, Arjun; Pasic, Ivan; Novitzky-Basso, Igor; Viswabandya, Auro; Michelis, Fotios V.; Mattsson, Jonas; Kumar, Rajat
Herpes zoster frequency and adjuvanted recombinant zoster vaccination after allogeneic hematopoietic cell transplantation

带状疱疹频率及异基因造血细胞移植后的佐剂重组带状疱疹疫苗接种

Transplantation and Cellular Therapy
IF4.4
2025-10-280
PRE
Victoria G Hall; Caden Chiarello; Mats Remberger; Deepali Kumar; Ivan Pasic; Dennis Dong Hwan Kim; Rajat Kumar; Auro Viswabandya; Fotios V Michelis; Arjun Law; Armin Gerbitz; Sapna Humar; Wilson Lam; Igor Novitzky-Basso; Jonas Mattsson
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival

真实世界中，关于重度预治疗且对糖皮质激素难治的慢性移植物抗宿主病患者接受belumosudil治疗的加拿大数据：治疗结局及无失败生存期的风险因素分析

Annals of Hematology
IF2.4
2025-10-250
OA
Sergio Rodriguez-Rodriguez; Nihar Desai; Christopher Lemieux; Keven Vachon; Kareem Jamani; Mohamed Elemary; Tommy Alfaro-Moya; Eshrak Al-Shaibani; Ivan Pasic; Igor Novitzky-Basso; Fotios Michelis; Auro Viswabandya; Rajat Kumar; Jonas Mattsson; Arjun Law; Sylvie Lachance; Dennis Dong Hwan Kim
Size does not always matter: limited impact of donor-recipient weight difference on outcomes of adult allogeneic peripheral blood stem cell hematopoietic cell transplantation

体重差异并不总是重要：供受体体重差异对成人同种异基因外周血干细胞造血细胞移植结局的有限影响

Transplantation and Cellular Therapy
IF4.4
2025-10-060
PRE
Caden Chiarello; Sihath Singhabahu; Mats Remberger; Carol Chen; Tommy Alfaro Moya; Eshrak Al-Shaibani; Armin Gerbitz; Dennis Dong Hwan Kim; Rajat Kumar; Wilson Lam; Arjun Datt Law; Jeffrey H. Lipton; Fotios V. Michelis; Igor Novitzky-Basso; Auro Viswabandya; Jonas Mattsson; Ivan Pasic
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxis

能否超越骨髓清除性预处理（MAC）？一项在年龄小于65岁的异基因造血细胞移植患者中使用ATG-PTCy-CSA预防GVHD的MAC与减低强度预处理（RIC）的比较研究

British Journal of Haematology
IF3.8
2025-09-180
PRE
Ruah Alyamany; Ahmed Alnughmush; Mats Remberger; Arjun Datt Law; Wilson Lam; Dennis (Dong Hwan) Kim; Fotios V. Michelis; Ivan Pasic; Igor Novitzky-Basso; Armin Gerbitz; Rajat Kumar; Jonas Mattsson; Auro Viswabandya
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment

内皮活化与应激指数（EASIX）作为预测鲁索利替尼治疗糖皮质激素难治性急性移植物抗宿主病的失败生物标志物

British Journal of Haematology
IF3.8
2025-09-140
OAAI
Sergio Rodriguez-Rodriguez; Nihar Desai; Carol Chen; Kareem Jamani; Catherine Sohier-Poirier; Christopher Lemieux; Jennifer White; Mohamed Elemary; Michael Kennah; Tommy Alfaro Moya; Eshrak Al-Shaibani; Igor Novitzky-Basso; Ivan Pasic; Arjun Datt Law; Fotios V. Michelis; Auro Viswabandya; Rajat Kumar; Jonas Mattsson; Dennis Dong Hwan Kim
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation

使用ATG和PTCy预防匹配无关供者异基因造血细胞移植中移植物抗宿主病十年的经验

British Journal of Haematology
IF3.8
2025-08-270
PRE
Nihar Desai; Sergio Rodriguez-Rodriguez; Eshrak Al-Shaibani; Tommy Alfaro Moya; Arjun Datt Law; Igor Novitzky-Basso; Ivan Pasic; Fotios V. Michelis; Rajat Kumar; Dennis Dong Hwan Kim; Jonas Mattsson; Auro Viswabandya
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation

异基因造血干细胞移植后，移植物抗宿主病预防措施对第二原发恶性肿瘤的影响

British Journal of Haematology
IF3.8
2025-07-190
PRE
Nihar Desai; Eshrak Al-Shaibani; Tommy Alfaro-Moya; Arjun D. Law; Wilson Lam; Mats Remberger; Ivan Pasic; Igor Novitzky-Basso; Auro Viswabandya; Dennis D. Kim; Rajat Kumar; Jeffrey H. Lipton; Jonas Mattsson; Fotios V. Michelis
Effect of Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide on GvHD Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia

抗胸腺细胞球蛋白和移植后环磷酰胺对女性供者至男性受者配型无关供者异基因造血干细胞移植治疗急性白血病中GVHD预后的影响

Transplantation and Cellular Therapy
IF4.4
2025-07-130
PRE
Nihar Desai; Sergio Rodriguez-Rodriguez; Mats Remberger; Eshrak Al-Shaibani; Tommy Alfaro-Moya; Igor Novitzky-Basso; Ivan Pasic; Fotios V. Michelis; Auro Viswabandya; Dennis Dong Hwan Kim; Rajat Kumar; Jonas Mattsson; Arjun D. Law
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant With Graft Failure and Relapse Risk in Hematological Malignancies

异基因造血细胞移植后环孢素暴露与血液系统恶性肿瘤中移植物失败和复发风险的关系

Transplantation and Cellular Therapy
IF4.4
2025-06-110
PRE
Ahmed Alnughmush; Mats Remberger; Vathany Kulasingam; Ivan Pasic; Igor Novitzky-Basso; Arjun D. Law; Wilson Lam; Dennis D. Kim; Armin Gerbitz; Rajat Kumar; Auro Viswabandya; Jonas Mattsson; Fotios V. Michelis
Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure

自体骨髓移植失败患者进行第二次异基因造血干细胞移植的预处理方案

Transplantation and Cellular Therapy
IF4.4
2025-06-110
PRE
Nihar Desai; Sergio Rodriguez Rodriguez; Carol Chen; Eshetu G. Atenafu; Tommy Alfaro-Moya; Arjun Datt Law; Eshrak Al-Shaibani; Igor Novitzky-Basso; Ivan Pasic; Fotios V. Michelis; Auro Viswabandya; Dennis D. Kim; Jonas Mattsson; Rajat Kumar
Prolonged length of stay in high-risk patients undergoing allogeneic stem cell transplantation: a call to action for addressing healthcare challenges

高危患者接受异基因干细胞移植时的长期住院：应对医疗保健挑战的呼吁

Bone Marrow Transplantation
IF5.2
2025-06-030
PRE
Ayman Sayyed; Igor Novitzky-Basso; Mats Remberger; Susan Clarke; Carol Chen; Eshrak Al-Shaibani; Dennis D. H. Kim; Auro Viswabandya; Rajat Kumar; Wilson Lam; Arjun D. Law; Armin Gerbitz; Ivan Pasic; Fotios V. Michelis; Jonas Mattsson
Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

移植后环磷酰胺在匹配同胞供者异基因移植老年患者中的耐受性与疗效：一项回顾性分析

BLOOD
IF23.1
2024-11-050
PRE
Desai, Nihar; Moya, Tommy Alfaro; Novitzky-Basso, Igor; Pasic, Ivan; Lam, Wilson; Michelis, Fotios; Gerbitz, Armin; Viswabandya, Auro; Kim, Dennis Dong Hwan; Kumar, Rajat; Mattsson, Jonas; Law, Arjun
Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

在AML患者中，对于65岁以下人群，采用抗胸腺细胞球蛋白与移植后环磷酰胺联合作为GVHD预防措施时，可改善预后。

BLOOD
IF23.1
2024-11-050
PRE
Alnughmush, Ahmed; Alyamany, Ruah; Remberger, Mats; Pasic, Ivan; Novitzky-Basso, Igor; Law, Arjun; Lam, Wilson; Kim, Dennis Dong Hwan; Michelis, Fotios; Gerbitz, Armin; Kumar, Rajat; Mattsson, Jonas; Viswabandya, Auro
Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

相对于减低强度预处理，在65岁以下MDS患者中使用抗胸腺细胞球蛋白和移植后环磷酰胺联合方案作为GvHD预防措施时，观察到更强的生存优势。

BLOOD
IF23.1
2024-11-050
PRE
Alnughmush, Ahmed; Alyamany, Ruah; Remberger, Mats; Pasic, Ivan; Novitzky-Basso, Igor; Law, Arjun; Lam, Wilson; Kim, Dennis Dong Hwan; Michelis, Fotios; Gerbitz, Armin; Kumar, Rajat; Mattsson, Jonas; Viswabandya, Auro
Strength to Endure: Superiority of MAC over RIC in Patients < 65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

耐受性优势：在年龄小于65岁、使用ATG-Ptcy-CSA进行GvHD预防的干细胞移植患者中，MAC方案优于RIC方案

BLOOD
IF23.1
2024-11-050
PRE
Alyamany, Ruah; Alnughmush, Ahmed; Remberger, Mats; Michelis, Fotios; Law, Arjun D.; Lam, Wilson; Kim, Dennis Dong Hwan; Pasic, Ivan; Novitzky-Basso, Igor; Gerbitz, Armin; Kumar, Rajat; Mattsson, Jonas; Viswabandya, Auro
Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: 一项回顾性队列研究

BLOOD
IF23.1
2024-11-050
PRE
Desai, Nihar; Law, Arjun; Novitzky-Basso, Igor; Pasic, Ivan; Lam, Wilson; Michelis, Fotios; Gerbitz, Armin; Kim, Dennis Dong Hwan; Kumar, Rajat; Mattsson, Jonas; Viswabandya, Auro

研究方向

暂未获取到该数据
A
Auro Viswabandya
H 指数:34论文数:451被引数:4,625
A
Arjun Law
H 指数:22论文数:269被引数:1,780
J
Jonas Mattsson
H 指数:53论文数:538被引数:9,526
R
Rajat Kumar
H 指数:28论文数:366被引数:3,887
I
Ivan Pašić
H 指数:16论文数:179被引数:941
W
Wilson Lam
H 指数:22论文数:337被引数:1,739
D
Dennis Dong Hwan Kim
H 指数:35论文数:419被引数:1.1万
I
Igor Novitzky‐Basso
H 指数:18论文数:165被引数:2,301
J
Jeffrey H. Lipton
H 指数:58论文数:732被引数:1.7万
A
Armin Gerbitz
H 指数:30论文数:215被引数:3,996